Editorial Comment from Dr Szarvas and Dr Reis to Clinicopathological features of malignant urachal tumor: A hospital-based cancer registry data in Japan

Tibor Szarvas^{1

2}, Henning Reis³

Affiliations

¹ Department of Urology, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany.
² Department of Urology, Semmelweis University, Budapest, Hungary.
³ Institute of Pathology, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany.

Comment

Tibor Szarvas et al. Int J Urol. 2020 Feb.

. 2020 Feb;27(2):163-164.

doi: 10.1111/iju.14164. Epub 2019 Dec 4.

Tibor Szarvas^{1

2}, Henning Reis³

¹ Department of Urology, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany.
² Department of Urology, Semmelweis University, Budapest, Hungary.
³ Institute of Pathology, Faculty of Medicine, University of Duisburg-Essen, Essen, Germany.

No abstract available

Comment on

Clinicopathological features of malignant urachal tumor: A hospital-based cancer registry data in Japan.
Nagumo Y, Kojima T, Shiga M, Kojo K, Tanaka K, Kandori S, Kimura T, Kawahara T, Kawai K, Okuyama A, Higashi T, Nishiyama H. Nagumo Y, et al. Int J Urol. 2020 Feb;27(2):157-162. doi: 10.1111/iju.14154. Epub 2019 Dec 2. Int J Urol. 2020. PMID: 31793080

1. Wright JL, Porter MP, Li CI, Lange PH, Lin DW. Differences in survival among patients with urachal and nonurachal adenocarcinomas of the bladder. Cancer 2006; 107: 721-8.
1. Pinthus JH, Haddad R, Trachtenberg J et al. Population based survival data on urachal tumors. J. Urol. 2006; 175: 2042-7.
1. Bruins HM, Visser O, Ploeg M et al. The clinical epidemiology of urachal carcinoma: results of a large, population based study. J. Urol. 2012; 188: 1102-7.
1. Collins DC, Velázquez-Kennedy K, Deady S, Brady AP, Sweeney P, Power DG. National incidence, management and survival of urachal carcinoma. Rare Tumors 2016; 8: 6257.
1. Hager T, Kraywinkel K, Niedworok C et al. Urachal carcinoma - clinical epidemiology in Germany and the USA. Pathologe 2019; 40: 170.